Safety and tolerability of injectable Rilpivirine LA in HPTN 076: A phase 2 HIV pre-exposure prophylaxis study in women is a research paper published in EClinicalMedicine (2020). On theSindex it has a DataRank of 0. It has been cited 24 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
HIV Prevention Trials Network
Grant: UM1 AI068619
HPTN Laboratory Centre
Grant: UM1-AI068613
NIAID NIH HHS
Grant: UM1 AI068617
NIAID NIH HHS
Grant: U01 AI069436
NIAID NIH HHS
Grant: UM1 AI068613
NIAID NIH HHS
Grant: UM1 AI069436
NIAID NIH HHS
Grant: UM1 AI069470
NIAID NIH HHS
Grant: UM1 AI069419
National Institutes of Health
Grant: 5UM1AI068613-16
LC: HIV PREVENTION TRIALS NETWORK
National Institutes of Health
Grant: 5UM1AI068619-09
LOC: HIV Prevention Trials Network
Fields of Study
Keywords
Sustainable Development Goals